What have we learnt from community-acquired infections in Hong Kong?

被引:8
|
作者
Ling, JM [1 ]
Lam, AW [1 ]
Chan, EW [1 ]
Cheng, AE [1 ]
机构
[1] Chinese Univ Hong Kong, Dept Microbiol, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China
关键词
community-acquired infections; antimicrobial susceptibilities;
D O I
10.1093/jac/dkg167
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This study was initiated throughout Hong Kong, to reveal the characteristics of community-acquired infections. All specimens collected by general practitioners from infected patients were followed prospectively, and those that were culture-positive were analysed. Four thousand seven hundred and forty-one specimens were collected from 3977 patients by 89 doctors from July 2000 to October 2001. The most common specimens were throat swabs (33%), urine (26%) and sputa (16%). The average culture-positive rate was 28%. The most common organisms were Escherichia coli (18%), beta-haemolytic streptococci (15%) and Staphylococcus aureus (12%). Fluoroquinolone resistance was relatively high (up to 35%) in organisms commonly causing urinary tract infection (E. coli, Proteus and Morganella). Although none of the pneumococci was resistant to penicillin 1 mg/L, the proportion with intermediate resistance (0.1-1 mg/L) was alarming (81%). There were three strains of methicillin-resistant S. aureus. A decrease in ampicillin resistance but a high prevalence of macrolide resistance were noted in Haemophilus influenzae. All Neisseria gonorrhoeae isolates were resistant to penicillin, up to 79% to the fluoroquinolones, 15% to spectinomycin, but all were susceptible to ceftriaxone. Respiratory pathogens (Streptococcus pneumoniae, P-haemolytic streptococci and H. influenzae) were relatively susceptible to the newer fluoroquinolones (0-2%, 0.5-6% and 2% resistant, respectively) or third-generation cephalosporins (0-2% resistant). The distribution of organisms and their antibiotic resistance varied over time. Thus frequent surveillance is needed to provide information on the drugs of choice for different infections.
引用
收藏
页码:895 / 904
页数:10
相关论文
共 50 条
  • [1] Antimicrobial treatment of community-acquired pneumonia in Hong Kong
    You, JHS
    Lee, VWY
    Au, PSL
    Lee, KKC
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (18) : 1785 - 1786
  • [2] PREVALENCE OF AMPICILLIN-RESISTANT HAEMOPHILUS-INFLUENZAE IN COMMUNITY-ACQUIRED INFECTIONS IN HONG-KONG
    LING, JM
    LAM, AW
    CHENG, AF
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 (02) : 346 - 347
  • [3] A PROSPECTIVE-STUDY OF COMMUNITY-ACQUIRED PNEUMONIA IN HONG-KONG
    CHAN, CHS
    COHEN, M
    PANG, J
    [J]. CHEST, 1992, 101 (02) : 442 - 446
  • [4] An unprecedented outbreak investigation for nosocomial and community-acquired legionellosis in Hong Kong
    CHENG Vincent Chi-chung
    WONG Samson Sai-yin
    CHEN Jonathan Hon-kwan
    CHAN Jasper Fuk-woo
    TO Kelvin Kai-wang
    POON Rosana Wing-shan
    WONG Sally Cheuk-ying
    CHAN Kwok-hung
    TAI Josepha Wai-ming
    HO Pak-leung
    TSANG Thomas Ho-fai
    YUEN Kwok-yung
    [J]. 中华医学杂志(英文版), 2012, (23) : 4283 - 4290
  • [5] An unprecedented outbreak investigation for nosocomial and community-acquired legionellosis in Hong Kong
    Cheng, Vincent Chi-chung
    Wong, Samson Sai-yin
    Chen, Jonathan Hon-kwan
    Chan, Jasper Fuk-Woo
    To, Kelvin Kai-wang
    Poon, Rosana Wing-shan
    Wong, Sally Cheuk-ying
    Chan Kwok-hung
    Tai, Josepha Wai-ming
    Ho Pak-leung
    Tsang, Thomas Ho-fai
    Yuen Kwok-yung
    [J]. CHINESE MEDICAL JOURNAL, 2012, 125 (23) : 4283 - 4290
  • [6] From deinstitutionalization to recovery-oriented assertive community treatment in Hong Kong: What we have achieved
    Lee, Chi C.
    Liem, Shu K.
    Leung, Joey
    Young, Vicky
    Wu, Kitty
    Kenny, Kenny K. Wong
    Yuen, Sui K.
    Lee, Wai F.
    Leung, Tom
    Shum, Mannix
    Kwong, Patrick
    Lo, William
    [J]. PSYCHIATRY RESEARCH, 2015, 228 (03) : 243 - 250
  • [7] What have we learnt from Vioxx?
    Krumholz, Harlan
    Ross, Joseph S.
    Presler, Amos H.
    Egilman, David S.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2007, 334 (7585): : 120 - 123
  • [8] What Have We Learnt from 2020?
    Roach, V.
    [J]. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2021, 61 : 139 - 139
  • [9] What have we learnt from AIDS?
    Pinching, AJ
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1997, 50 (11) : 885 - 886
  • [10] What have we learnt from SARS?
    Weiss, RA
    McLean, AR
    [J]. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2004, 359 (1447) : 1137 - 1140